Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers

R. L. Piekarz; R. Frye; M. Turner; J. Wright; S. Allen; M. H. Kirschbaum; J. Zain; M. Prince; L. Hutchins; L. C. Showe; W. D. Figg; T. Fojo; S. E. Bates

Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers

R. L. Piekarz, R. Frye, M. Turner, J. Wright, S. Allen, M. H. Kirschbaum, J. Zain, M. Prince, L. Hutchins, L. C. Showe, W. D. Figg, T. Fojo, S. E. Bates

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	29-31
Number of pages	3
Journal	Haematologica Reports
Volume	2
Issue number	13
State	Published - 2006
Externally published	Yes

Cite this

@article{f8afd8d222af41e6b087662303ff6123,

title = "Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers",

author = "Piekarz, {R. L.} and R. Frye and M. Turner and J. Wright and S. Allen and Kirschbaum, {M. H.} and J. Zain and M. Prince and L. Hutchins and Showe, {L. C.} and Figg, {W. D.} and T. Fojo and Bates, {S. E.}",

year = "2006",

language = "English",

volume = "2",

pages = "29--31",

journal = "Haematologica Reports",

issn = "1824-9337",

number = "13",

}

TY - JOUR

T1 - Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma

T2 - Clinical activity and molecular markers

AU - Piekarz, R. L.

AU - Frye, R.

AU - Turner, M.

AU - Wright, J.

AU - Allen, S.

AU - Kirschbaum, M. H.

AU - Zain, J.

AU - Prince, M.

AU - Hutchins, L.

AU - Showe, L. C.

AU - Figg, W. D.

AU - Fojo, T.

AU - Bates, S. E.

PY - 2006

Y1 - 2006

UR - http://www.scopus.com/inward/record.url?scp=46849090744&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:46849090744

SN - 1824-9337

VL - 2

SP - 29

EP - 31

JO - Haematologica Reports

JF - Haematologica Reports

IS - 13

ER -

Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers

Fingerprint

Cite this